{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: While nocistatin ( 0 . 5 - 5 . 0 nmol mouse - 1 , i . c . v . ) administered 30 min before spontaneous alternation performance or the training session of the passive avoidance task , had no effect on spontaneous alternation or passive avoidance behaviours , a lower per cent alternation and shorter median step - down latency in the retention test were obtained in nociceptin ( 1 . 5 and / or 5 . 0 nmol mouse - 1 , i . c . v . ) - treated normal mice .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| Spontaneous alternation |\n| Passive avoidance behaviours |\n| Retention test |\n\nThe paragraph does not mention any disease entities. The mentioned terms - spontaneous alternation, passive avoidance behaviors, and retention test - are not diseases but rather behavioral phenomena or psychological tests used to assess memory and cognitive function in mice."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Sure, here's the updated table with the valid entities that clearly refer to \"Disease\":\n\n| Disease |\n| --- |\n| None mentioned |\n\nThe paragraph does not mention any specific disease entities."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: While nocistatin ( 0 . 5 - 5 . 0 nmol mouse - 1 , i . c . v . ) administered 30 min before spontaneous alternation performance or the training session of the passive avoidance task , had no effect on spontaneous alternation or passive avoidance behaviours , a lower per cent alternation and shorter median step - down latency in the retention test were obtained in nociceptin ( 1 . 5 and / or 5 . 0 nmol mouse - 1 , i . c . v . ) - treated normal mice .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| Nocistatin |\n| Nociceptin |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Sure, here's the updated table with the valid chemical entities:\n\n| Chemical |\n| --- |\n| Nocistatin |\n| Nociceptin |"}
  ]
}